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Article type      : Editorial 
Polygenic risk scores 
What are polygenic risk scores (PGRSs) and why are they relevant to nurses? 
Nurses need to know about genetics and most Registered Nurse learns ‘the essentials’ in an 
undergraduate curriculum. This is to ensure that they understand, for example, genetic sex 
determination and the genetic basis of some disorders which they may encounter in their 
patients. Some nurses go on to work in areas where advanced knowledge of genetics is 
important. Specialised nurses have long offered genetic counselling to couples where some 
familial disorders such as haemophilia, sickle cell anaemia and Huntington’s disease are 
present and in communities where consanguineous marriage is common (Salway, Ali, 
Ratcliffe, Such, Khan, Kingston, Quarrell, 2016; Ali, Salway, Such, Dearden 2018). More 
recently nurses will work in areas where gene therapies are being developed. However, gene 
therapies largely remain under development and where nurses work as genetic counsellors, it 
is mainly with genetic disorders that are well understood in terms of their heritability. Only 
single gene mutations are present, they are usually recessive and sometimes sex-linked. 
Therefore, specific advice can be offered about the likelihood of having a child with a genetic 
disorder and what the likely consequences for the child and the family will be. 
But imagine if nurses were able to advise people about their own likelihood—or ‘risk’—of 
developing a disease in later life, based on their whole genome, and what they could do to 
minimise the risk or adapt to it? This is precisely what PGRSs afford us; a tool in the 
genomic toolbox which estimates risk of almost any disease provided we have the necessary 
minimal information about a person’s genome. PGRSs are not brand new. However, they are 
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becoming much more useful due to technological advances which allow rapid genetic 
sequencing and analysis of very large populations. Based on these definitive samples, 
increasingly accurate estimates of the likelihood of a particular outcome in an individual are 
possible. 
 
What is a PGRS? 
PGRSs are also referred to as genome-wide polygenic scores and genetic risk scores (Khera, 
Chaffin, Aragam, Haas, Roselli, Choi, Natarajan, Lander, Lubitz, Ellinor, & Kathiresan, 
2018). A PGRS is a value that indicates the likelihood of an outcome developing due to a 
person’s genome. This likelihood is commonly referred to as a ‘risk’ because PGRSs are 
usually used to investigate diseases. However, you can have a PGRS for any trait such as 
height, sporting ability or mental ability (Plomin, van Stumm, 2018). A PGRS accounts for 
all the genes known to influence a particular outcome and weights some of these according to 
how strongly they are known to be associated with that outcome (Khera, et al., 2018). PRGSs 
have increased in popularity and in utility as they are becoming better. Clearly, the more 
information we have about a trait, the better it can be predicted. Information comes from the 
samples that already exist; and these samples are becoming bigger. The importance of such 
large samples—often in the millions—is realised through the existence of, long-standing, 
longitudinal studies such as the Lothian Birth Cohort Study 
(http://www.lothianbirthcohort.ed.ac.uk/; accessed 31 March 2019 ) and the pooling of data 
from many such large studies, for example, in the UK Biobank study 
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How it works 
From a sample of blood, or by scraping some cells from the inside of the mouth, the genetic 
profile of an individual can be determined and all factors which are known to be associated 
with specific outcomes, for example, coronary heart disease (CHD; Knowles & Ashley, 
2018), can be identified. Based on the studies of large samples referred to above, the risk of 
the individual person who has provided the sample developing CHD can be estimated and 
expressed as a number. The possibilities for scaling up such a procedure are immense as a 
visit to hospital is not required. Home kits are already available for the provision of samples 
for genetic testing (https://www.health.harvard.edu/newsletter_article/direct-to-consumer-
genetic-testing-kits; accessed 31 March 2019) and these could be ordered and returned to a 
laboratory specialising in PGRSs and the results returned to you. Clearly there may have to 
be subsequent follow-up with expert clinicians (including appropriately educated nurses) and 
an understanding conveyed that such tests and the values of PGRSs obtained are neither 
diagnostic nor predictive—merely indicative. Based on a person’s PGRS advice could be 
provided about what the score means, and from an evidence-based perspective, appropriate 
advice could be provided. Using CHD as an example, advice about smoking, body weight 
and exercise would be relevant. Of course, such advice is relevant and helpful to anyone; but 
they are more likely to listen if they have some evidence that they are at higher risk. 
What we know 
In theory, there is no limit to what can be estimated using PGRSs but some specific examples 
of PGRSs for non-communicable diseases (NCDs) including CHD, type-2 diabetes, 
inflammatory disease and breast cancer exist (Khera, et al., 2018). While the potential for a 
low-cost method of indicating risk and providing health professionals with a useful starting 
point for individualised health promotion, PGRSs remain untested clinically (Knowles, & 
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outcomes would be ideal; but given the length of time between genetic testing and the 
development of NCDs, this is likely to take decades to achieve. Also, there is criticism that 
PGRSs—largely generated from Caucasian samples—may not apply across other ethnic 
groups (Khera, et al., 2018). 
Nevertheless, it is not inconceivable that PGRSs could be generated for a wider range of 
ethnic groups and that they could be tested robustly. Given the evidence for their potential, 
their increasing accuracy and the ease with which an individual’s PGRS can be obtained, they 
are likely to become incorporated into clinical practice, especially in preventive medicine and 
health promotion. On the other hand, the ease with which genetic testing can be done, the 
natural concern that people have for their health and the widespread existence of medical 
charlatans who—playing on people’s concerns—may use this to peddle expensive, 
ineffective and possibly dangerous ‘remedies’. All the more reason for educated health 
professionals—with nurses at the forefront—to be knowledgeable about PGRSs and to be 
prepared to counsel patients and conduct their own research.  
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